AIM ImmunoTech Inc.
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viruses, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, and HIV. The company also provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with UMN Pharma Inc.; Japanese National Institute of Infectious Diseases; and Shionogi & Co., Ltd.; Polysciences Inc.; and University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1990 and is headquartered in Ocala, Florida. Show More...
-
Website http://www.aimimmuno.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.09 USD
-
Last Updated 04-04-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -52.8 -36.96 -63.36 -52.8 -48.84 -33.88 -14.96 -12.76 -9.77 -2.62 0.07 Dividends USD Payout Ratio % * Shares Mil 1.0 1.0 4.0 8.0 Book Value Per Share * USD 182.7 157.94 141.76 100.65 68.24 49.42 30.23 13.44 5.81 1.26 1.18 Free Cash Flow Per Share * USD -51.03 -39.72 -71.52 -66.14 -40.7 -40.81 -19.14 -15.39 -10.01 -5.59 Return on Assets % -22.52 -18.94 -34.29 -36.23 -56.93 -58.3 -36.0 -49.93 -69.96 -55.97 -34.18 Financial Leverage (Average) 1.12 1.15 1.29 1.09 1.18 1.12 1.22 1.63 2.68 1.67 1.23 Return on Equity % -24.25 -21.49 -41.99 -43.85 -64.27 -67.13 -41.83 -68.25 -141.43 -110.19 -55.81 Return on Invested Capital % -27.02 -21.77 -44.54 -45.85 -66.58 -68.69 -42.55 -58.9 -74.13 -62.11 -39.35 Interest Coverage -348.66 -722.08 -58.42 -18.55 -21.33 -18.83 Current Ratio 12.95 6.27 3.54 7.32 3.72 4.34 2.85 1.29 0.72 9.27 42.26 Quick Ratio 12.57 5.98 3.47 7.19 3.63 3.66 2.41 0.79 0.55 8.52 41.13 Debt/Equity 0.010 0.21 0.45 0.51 0.18